Diminazene Aceturate Ameliorates Hypertension‐Induced Cognitive Impairment by Disrupting the CCN1–Integrin αvβ6–TGF‐β Axis and Preserving Mitochondrial Integrity
The FASEB Journal · 2026
DOI: 10.1096/fj.202503973r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Xufang Huo und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Anesthesiology, Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Diminazene, Hypertension, Mitochondria, Transforming Growth Factor beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Guizhou Provincial Science and Technology Plan Project, Guizhou Provincial Science and Technology Foundation,, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Hypertension is a critical risk factor for vascular cognitive impairment; however, the precise molecular mechanisms underlying hypertension‐induced neuronal injury remain poorly understood, hindering the development of effective neuroprotective strategies. Diminazene aceturate (DIZE), an activator of angiotensin‐converting enzyme 2 (ACE2), has demonstrated neuroprotective effects in various neurological injury models, though its mechanisms in hypertensive brain damage are unknown. Here, we investigate the role of the matricellular protein CCN1 in hypertension‐associated cognitive impairment and elucidate the potential neuroprotective mechanisms conferred by DIZE. A total of 80 genes were identified using RNA sequencing of HT22 hippocampal neurons treated with angiotensin II (AngII) alone or AngII plus DIZE, with CCN1 emerging as a hub linking mitochondrial dysfunction, autophagy, and oxidative stress pathways. In vitro, AngII‐induced CCN1 upregulation, mitochondrial dysfunction, membrane‐potential collapse, and excessive reactive oxygen species production were rescued by DIZE co‐treatment. Mechanistically, CCN1 activated integrin αvβ6–TGF‐β signaling to mediate neuronal injury, as these detrimental effects induced by AngII were abolished by genetic CCN1 knockdown or pharmacological blockade of integrin αvβ6 or TGF‐β receptor 1, confirming a CCN1–αvβ6–TGF‐β signaling axis. Actinomycin D transcription inhibition assays demonstrated that DIZE suppressed CCN1 at the post‐transcriptional level, specifically by accelerating CCN1 mRNA degradation and reducing its half‐life, thereby restoring mitochondrial integrity. Building on these mechanistic insights, chronic hypertension was induced in mice by continuous subcutaneous AngII infusion. AngII‐induced spatial‐memory and object‐recognition deficits in Barnes maze, novel object recognition, and Y‐maze tests were largely reversed by DIZE treatment, demonstrating that restoration of mitochondrial function through CCN1 destabilization ameliorates hypertension‐related cognitive impairment. We identify a novel CCN1–integrin αvβ6–TGF‐β–mitochondrial dysfunction signaling axis as a key mediator of hypertension‐induced cognitive impairment and demonstrate that DIZE confers neuroprotective effects through post‐transcriptional suppression of CCN1 via accelerated mRNA degradation. These findings advance our mechanistic understanding of hypertensive brain injury and establish a rational foundation for the clinical development of CCN1‐targeted therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Anesthesiology, Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Anesthesiology, The First People's Hospital of Guiyang, Guiyang, Guizhou, China.
- Department of Anesthesiology, The Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Emergency, The First People's Hospital of Guiyang, Guiyang, Guizhou, China.
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Hainan International Medical Center, Shanghai Jiao Tong University School of Medicine, Hainan, China.
ORCID-Profile: Qingfan Zeng
Förderung
- the Guizhou Provincial Science and Technology Plan Project
- Guizhou Provincial Science and Technology Foundation,
- the National Natural Science Foundation of China
- the Zunyi Science and Technology Cooperation Program
- the Science and Technology Project of the Health Commission of Guiyang City
- National Natural Science Foundation of China
Zitieren
APA
Huo, X., Wu, Z., Zhou, X., Zhou, Y., Liu, J., Li, H., Wu, Y., Huang, Y., Feng, G., Hu, X., & Zeng, Q. (2026). Diminazene Aceturate Ameliorates Hypertension‐Induced Cognitive Impairment by Disrupting the CCN1–Integrin αvβ6–TGF‐β Axis and Preserving Mitochondrial Integrity. The FASEB Journal. https://doi.org/10.1096/fj.202503973r
Vancouver
Huo X, Wu Z, Zhou X, Zhou Y, Liu J, Li H, et al. Diminazene Aceturate Ameliorates Hypertension‐Induced Cognitive Impairment by Disrupting the CCN1–Integrin αvβ6–TGF‐β Axis and Preserving Mitochondrial Integrity. The FASEB Journal. 2026. doi:10.1096/fj.202503973r
BibTeX
@article{Huo2026,
author = {Huo, Xufang and Wu, Zhenyu and Zhou, Xinqian and Zhou, Yuancheng and Liu, Jiming and Li, Hongbing and Wu, Yijiu and Huang, You and Feng, Guangling and Hu, Xiaolin and Zeng, Qingfan},
title = {Diminazene Aceturate Ameliorates Hypertension‐Induced Cognitive Impairment by Disrupting the CCN1–Integrin αvβ6–TGF‐β Axis and Preserving Mitochondrial Integrity},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202503973r}
}
EUVIMED